Roberta D’Ambrosio

4.9k total citations
104 papers, 2.1k citations indexed

About

Roberta D’Ambrosio is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Roberta D’Ambrosio has authored 104 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hepatology, 86 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Roberta D’Ambrosio's work include Liver Disease Diagnosis and Treatment (82 papers), Hepatitis C virus research (77 papers) and Hepatitis B Virus Studies (38 papers). Roberta D’Ambrosio is often cited by papers focused on Liver Disease Diagnosis and Treatment (82 papers), Hepatitis C virus research (77 papers) and Hepatitis B Virus Studies (38 papers). Roberta D’Ambrosio collaborates with scholars based in Italy, United States and France. Roberta D’Ambrosio's co-authors include Alessio Aghemo, Maria Grazia Rumi, Massimo Colombo, Maria Francesca Donato, Elisabetta Degasperi, Massimo Colombo, R. Soffredini, Pietro Lampertico, Pierre Bédossa and Valérie Paradis and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Roberta D’Ambrosio

102 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta D’Ambrosio Italy	24	1.7k	1.6k	169	135	127	104	2.1k
Emanuel K. Manesis Greece	33	2.5k 1.5×	2.3k 1.4×	150 0.9×	167 1.2×	116 0.9×	80	3.0k
Ming‐Yen Hsieh Taiwan	23	1.8k 1.1×	1.8k 1.1×	130 0.8×	190 1.4×	159 1.3×	112	2.2k
Seigo Abiru Japan	22	965 0.6×	866 0.5×	250 1.5×	82 0.6×	142 1.1×	52	1.5k
Consuelo Soldevila‐Pico United States	22	1.5k 0.9×	1.4k 0.9×	116 0.7×	226 1.7×	55 0.4×	41	2.0k
Ziad Younes United States	22	1.3k 0.8×	882 0.5×	223 1.3×	228 1.7×	83 0.7×	67	1.8k
Davide Bitetto Italy	19	949 0.6×	846 0.5×	132 0.8×	84 0.6×	127 1.0×	60	1.5k
Spilios Manolakopoulos Greece	32	2.8k 1.6×	2.6k 1.6×	162 1.0×	137 1.0×	65 0.5×	128	3.4k
Annarosa Cussigh Italy	18	771 0.5×	624 0.4×	95 0.6×	93 0.7×	123 1.0×	31	1.2k
Antonio Ascione Italy	19	1.4k 0.8×	1.5k 0.9×	105 0.6×	65 0.5×	68 0.5×	53	1.7k
Manabu Daikoku Japan	17	777 0.5×	686 0.4×	127 0.8×	70 0.5×	54 0.4×	28	1.1k

Countries citing papers authored by Roberta D’Ambrosio

Since Specialization

Citations

This map shows the geographic impact of Roberta D’Ambrosio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta D’Ambrosio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta D’Ambrosio more than expected).

Fields of papers citing papers by Roberta D’Ambrosio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta D’Ambrosio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta D’Ambrosio. The network helps show where Roberta D’Ambrosio may publish in the future.

Co-authorship network of co-authors of Roberta D’Ambrosio

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta D’Ambrosio. A scholar is included among the top collaborators of Roberta D’Ambrosio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta D’Ambrosio. Roberta D’Ambrosio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caviglia, Gian Paolo, Piero Fariselli, Roberta D’Ambrosio, et al.. (2024). Development and Validation of a PIVKA‐II‐Based Model for HCC Risk Stratification in Patients With HCV‐Related Cirrhosis Successfully Treated With DAA. Alimentary Pharmacology & Therapeutics. 61(3). 538–549. 2 indexed citations

Iavarone, Massimo, Riccardo Perbellini, Sara Uceda Renteria, et al.. (2024). ASAP score may predict HCC recurrence after complete radiological response to locoregional treatments. Digestive and Liver Disease. 56. S89–S89. 1 indexed citations

Pelusi, Serena, Cristiana Bianco, Massimo Colombo, et al.. (2023). Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals. Liver International. 43(7). 1593–1603. 7 indexed citations

Kondili, Loreta A., Lucia Craxì, Felice Nava, et al.. (2023). From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy. The Journal of Infectious Diseases. 228(Supplement_3). S211–S220. 7 indexed citations

D’Ambrosio, Roberta, Angiola Spinetti, Massimo Puoti, et al.. (2023). A territory‐wide opportunistic, hospital‐based HCV screening in the general population from northern Italy: The 1969–1989 birth‐cohort. Liver International. 43(12). 2645–2656. 4 indexed citations

Aghemo, Alessio, Marcello Persico, Roberta D’Ambrosio, et al.. (2023). Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PLoS ONE. 18(2). e0280165–e0280165. 2 indexed citations

Scagliola, Alessandra, Annarita Miluzio, Stefania Oliveto, et al.. (2021). Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma. Nature Communications. 12(1). 4878–4878. 27 indexed citations

Colucci, Giuseppe, Federica Invernizzi, Sara Uceda Renteria, et al.. (2021). The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles. Viral Immunology. 34(8). 542–551. 3 indexed citations

D’Ambrosio, Roberta, Elisabetta Degasperi, Marta Borghi, et al.. (2021). Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR. Journal of Hepatology. 76(2). 302–310. 49 indexed citations

10.

D’Ambrosio, Roberta, Irene Campi, Marco Maggioni, et al.. (2021). The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLoS ONE. 16(4). e0249614–e0249614. 19 indexed citations

11.

Colucci, Giuseppe, Roberta D’Ambrosio, E. Galmozzi, et al.. (2018). Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver Damage. Viral Immunology. 31(5). 358–361. 1 indexed citations

12.

Degasperi, Elisabetta, Roberta D’Ambrosio, Massimo Iavarone, et al.. (2018). Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection. Clinical Gastroenterology and Hepatology. 17(6). 1183–1191.e7. 83 indexed citations

13.

Origa, Raffaella, Aldo Filosa, Alfonso Galeota Lanza, et al.. (2017). Treatment of hepatitis C virus infection with direct‐acting antiviral drugs is safe and effective in patients with hemoglobinopathies. American Journal of Hematology. 92(12). 1349–1355. 32 indexed citations

14.

Grancini, Valeria, Maddalena Trombetta, Maria Elena Lunati, et al.. (2015). Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease. Journal of Hepatology. 63(6). 1484–1490. 57 indexed citations

15.

Vermehren, Johannes, Alessio Aghemo, Kai‐Henrik Peiffer, et al.. (2013). 506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS. Journal of Hepatology. 58. S208–S208. 2 indexed citations

16.

D’Ambrosio, Roberta, Alessio Aghemo, Mirella Fraquelli, et al.. (2013). The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. Journal of Hepatology. 59(2). 251–256. 111 indexed citations

17.

Fabrizi, Fabrizio, Alessio Aghemo, Giovanni B. Fogazzi, et al.. (2013). Acute Tubular Necrosis Following Interferon-Based Therapy for Hepatitis C: Case Study with Literature Review. Kidney & Blood Pressure Research. 38(1). 52–60. 8 indexed citations

18.

D’Ambrosio, Roberta, et al.. (2012). Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir. Biologics. 6. 363–363. 1 indexed citations

19.

Nicola, Stella De, Alessio Aghemo, Maria Grazia Rumi, et al.. (2011). Interleukin 28B Polymorphism Predicts Pegylated Interferon Plus Ribavirin Treatment Outcome in Chronic Hepatitis C Genotype 4. Hepatology. 55(2). 336–342. 67 indexed citations

20.

Prati, Gian Maria, Alessio Aghemo, Maria Grazia Rumi, et al.. (2011). Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis. Journal of Hepatology. 56(2). 341–347. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact